Prashi Pharma Private Limited — Mebendazole Exporter Profile
Indian Pharmaceutical Exporter · #5 for Mebendazole · $398.2K export value · DGFT Verified
Prashi Pharma Private Limited is the #5 Indian exporter of Mebendazole with $398.2K in export value and 32 verified shipments. Prashi Pharma Private Limited holds a 2.9% market share in Mebendazole exports across 3 countries. The company exports 5 pharmaceutical products worth $2.9M across 4 therapeutic categories.
Prashi Pharma Private Limited — Mebendazole Export Profile: Buyers & Destinations
Where Does Prashi Pharma Private Limited Export Mebendazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $266.9K | 21 | 67.0% |
| CONGO | $129.8K | 8 | 32.6% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $1.5K | 3 | 0.4% |
Prashi Pharma Private Limited exports Mebendazole to 3 countries. The largest destination is CONGO, THE DEMOCRATIC REPUBLIC OF THE accounting for 67.0% of Prashi Pharma Private Limited's Mebendazole shipments, followed by CONGO (32.6%) and CONGO THE DEMOCRATIC REPUBLIC OF THE (0.4%). These destinations reflect Prashi Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Mebendazole from Prashi Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STE PRINCE PHARMA SARL | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $398.2K | 32 |
Prashi Pharma Private Limited supplies Mebendazole to 1 buyers globally. The largest buyer is STE PRINCE PHARMA SARL (CONGO, THE DEMOCRATIC REPUBLIC OF THE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Mebendazole Export Value and How Much Does Prashi Pharma Private Limited Contribute?
India exported $7.1M worth of Mebendazole through 2,932 shipments from 259 suppliers to 108 countries, serving 756 buyers globally. Prashi Pharma Private Limited contributes $398.2K to this total, accounting for 2.9% of India's Mebendazole exports. Prashi Pharma Private Limited ships Mebendazole to 3 countries through 1 buyers.
What Is the Average Shipment Value for Prashi Pharma Private Limited's Mebendazole Exports?
Prashi Pharma Private Limited's average Mebendazole shipment value is $12.4K per consignment, based on 32 shipments totaling $398.2K. The largest destination is CONGO, THE DEMOCRATIC REPUBLIC OF THE (67.0% of Prashi Pharma Private Limited's Mebendazole exports).
How Does Prashi Pharma Private Limited Compare to Other Indian Mebendazole Exporters?
Prashi Pharma Private Limited ranks #5 among 259 Indian Mebendazole exporters with a 2.9% market share. The top 3 exporters are CADILA PHARMACEUTICALS LIMITED ($2.7M), LINCOLN PHARMACEUTICALS LTD ($1.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($539.7K). Prashi Pharma Private Limited processed 32 shipments to 3 destination countries.
What Mebendazole Formulations Does Prashi Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEBENDA-100 TABLETS (MEBENDAZOLE TABLETS | $193.1K | 5 |
| MEBENDA-100 TABLETS (MEBENDAZOLE TABLETSUSP 100MG) EACH UNCOATED TABLET CONTAINS : MEBENDAZOLE USP 100MG | $73.8K | 16 |
| MEBENDA-100 TABLETS MEBENDAZOLE TABLETS | $64.7K | 2 |
| MEBENDA-100 TABLETS MEBENDAZOLE TABLETS USP 100MG EACH UNCOATED TABLET CONTAINS :MEBENDAZOLE USP 100MG | $37.6K | 1 |
| MEBENDA 100 TABLETS MEBENDAZOLE TABLETS USP 100MG EACH UNCOATED TABLETS CONTAINS MEBENDAZOLE USP 100MG | $21.7K | 2 |
| MEBENDA-100 TABLETS MEBENDAZOLE TABLETSUSP 100MG EACH UNCOATED TABLET CONTAINS : MEBENDAZOLE USP 100MG | $5.1K | 2 |
| MEBENDA-100 TABLETS (MEBENDAZOLE TABLETSUSP 100MG) EACH UNCOATED TABLET CONTAINS : MEBENDAZOLE USP 100MGNOS | $1.5K | 3 |
| MEBENDA-100 TABLETS MEBENDAZOLE TABLETSUSP 100 MG EACH UNCOATED TABLET CONTAINS : MEBENDAZOLE USP 100 MG | $680 | 1 |
Prashi Pharma Private Limited exports 8 distinct Mebendazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEBENDA-100 TABLETS (MEBENDAZOLE TABLETS with 5 shipments worth $193.1K.
How Does Prashi Pharma Private Limited Compare to Nearest Mebendazole Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | LINCOLN PHARMACEUTICALS LTD | $1.1M | 22 | 1 | $50.0K |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $539.7K | 94 | 4 | $5.7K |
| 5 | PRASHI PHARMA PRIVATE LIMITED ★ | $398.2K | 32 | 3 | $12.4K |
| 6 | BEID HEALTHCARE PRIVATE LIMITED | $318.2K | 40 | 2 | $8.0K |
| 7 | J B CHEMICALS PHARMACEUTICALS LIMITED | $313.9K | 40 | 4 | $7.8K |
Prashi Pharma Private Limited ranks #5 among 259 Indian Mebendazole exporters. Average shipment value of $12.4K compared to the market average of $27.3K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and J B CHEMICALS AND PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Mebendazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 17.5% |
| SAHAR AIR | 450 | 15.3% |
| NHAVA SHEVA SEA (INNSA1) | 300 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 289 | 9.9% |
| JNPT/ NHAVA SHEVA SEA | 170 | 5.8% |
| DELHI AIR | 162 | 5.5% |
| JNPT | 130 | 4.4% |
| AHEMDABAD ICD | 96 | 3.3% |
What Other Antimalarial & Antiparasitic Products Does Prashi Pharma Private Limited Export?
Prashi Pharma Private Limited also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
About Prashi Pharma Private Limited
Prashi Pharma Private Limited exports 5 products worth $2.9M. Beyond Mebendazole, top products include Tetracycline, Griseofulvin, Levamisole, Norfloxacin. View the complete Prashi Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mebendazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mebendazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Prashi Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching Prashi Pharma Private Limited exporting Mebendazole, covering 8 formulations to 3 countries via 1 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 756+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mebendazole Export Data from Prashi Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Prashi Pharma Private Limited's Mebendazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Prashi Pharma Private Limited
Full Company Profile →
5 products · $2.9M total trade · 4 categories
Mebendazole Stats
Company Overview
Top Products by Prashi Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Prashi Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mebendazole. For current shipment-level data, contact TransData Nexus.